Ctrl Worx Watch List › Company

Goldenwell Biotech, Inc. (GWLL): material weakness open at least 2,128 days

By Russell Tomoum, Ctrl Worx™. Built from its own SEC filings. How the Clock works.

Goldenwell Biotech, Inc. reported ineffective internal control over financial reporting because of a material weakness in 7 filings since Jul 23, 2021. The latest was its 10-K for the period ended Dec 31, 2025.

Checked against SEC EDGAR: Oct 29, 2026 · Entry #11547

Causes the company named

Segregation of duties · 7Entity-level and governance · 7

Lack of independent board oversight and inadequate segregation of duties in financial reporting controls.

What the latest filing says

Deficiencies existed in the design or operation of our internal controls over financial reporting that adversely affected our internal controls and that may be considered to be material weaknesses. The matters involving internal controls and procedures that our management considered to be material weaknesses under the standards of the Public Company Accounting Oversight Board were: (i) lack of a majority of independent members and a lack of a majority of outside directors on our board of directors, resulting in ineffective oversight in the establishment and monitoring of required internal controls and procedures; and (ii) inadequate segregation of duties consistent with control objectives. Management believes that the lack of a majority of outside directors on our board of directors results in ineffective oversight in the establishment and monitoring of required internal controls and procedures, which could result in a material misstatement in our financial statements in future periods. Auditor’s Report on Internal Control over Financial Reporting This Annual Report does not inclu [...]

From the controls section of the 10-K filed Jul 1, 2026. Read the full filing on SEC EDGAR.

Company response: Goldenwell Biotech, Inc. can send a statement or a link to its remediation update to russell@ctrlworx.com. We post it here, unedited and dated.

Filings

Follow GWLL for free

Get an email when Goldenwell Biotech, Inc files a 10-K or 10-Q that reports a material weakness, or says its controls are effective again.

Based on public SEC filings. Causes are grouped into standard categories by Ctrl Worx. The filings are the authority. Ctrl Worx is not affiliated with Goldenwell Biotech, Inc. or the SEC. Not investment advice. Why you can rely on the Watch List.